用于全层感染烧伤创面的抗菌伤口敷料
该研究开发了以医用级聚氨酯为涂层、含天然植物次生代谢物肉桂醛和α-松油醇的伤口敷料,采用浸涂法制备。体外浸渍24小时后定量菌落,对多种革兰阳性菌和革兰阴性菌实现>5-log(99.999%)减少,同时保持吸水性。在猪全层烧伤体内模型中,该敷料每日更换时降低细菌负荷优于杆菌肽,不干扰创面愈合,且对创床黏附显著更低。作者预计该敷料可用于多种急性和慢性伤口。
要点
- 体外浸渍24小时后,该敷料对多种革兰阳性菌和革兰阴性菌实现>5-log(99.999%)减少,同时保持吸水性。
- 在猪全层烧伤体内模型中,该敷料每日更换时降低细菌负荷优于杆菌肽,且不干扰创面愈合。
- 该敷料对创床的黏附显著低于杆菌肽,更换方便且不黏附创床。
- 该敷料减少临床相关细菌负荷多于市售抗菌伤口敷料,在感染烧伤创面模型中表现与杆菌肽相当或更好。
- 敷料成分为美国食品药品监督管理局(FDA)批准可供人食用的成分,采用浸涂法制备。
适用人群与场景
- 全层感染烧伤创面(猪体内模型);作者预计可用于多种急性和慢性伤口。
研究设计与关键结果
- 研究为体外抗菌实验联合猪全层烧伤体内模型,敷料采用浸涂法制备,涂层为含肉桂醛和α-松油醇的医用级聚氨酯。
- 体外抗菌效力通过浸渍24小时后定量细菌菌落测定,对多种革兰阳性菌和革兰阴性菌实现>5-log(99.999%)减少,同时保持吸水性。
- 在猪全层烧伤体内模型中,该敷料每日更换时降低细菌负荷优于杆菌肽,且不干扰创面愈合。
- 该敷料对创床的黏附显著低于杆菌肽。
- 该敷料减少临床相关细菌负荷多于市售抗菌伤口敷料;在感染烧伤创面体内模型中,其表现与杆菌肽相当或更好。
证据类型、等级与局限
- 证据类型:体外抗菌实验联合猪全层烧伤体内模型(动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者预计该敷料可用于多种急性和慢性伤口的治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Infection of wounds delays healing, increases treatment costs, and leads to major complications. Current methods to manage such infections include antibiotic ointments and antimicrobial wound dressings, both of which have significant drawbacks, including frequent reapplication and contribution to antimicrobial resistance. In this work, we developed wound dressings fabricated with a medical-grade polyurethane coating composed of natural plant secondary metabolites, cinnamaldehyde, and alpha-terpineol. Our wound dressings are easy to change and do not adhere to the wound bed. They kill gram-positive and -negative microbes in infected wounds due to the Food and Drug Administration-approved for human consumption components. The wound dressings were fabricated by dip coating. Antimicrobial efficacy was determined by quantifying the bacteria colonies after a 24 h of immersion. Wound healing and bacterial reduction were assessed in an in vivo full-thickness porcine burn model. Our antimicrobial wound dressings showed a > 5-log reduction (99.999%) of different gram-positive and gram-negative bacteria, while maintaining absorbency. In the in vivo porcine burn model, our wound dressings were superior to bacitracin in decreasing bacterial burden during daily changes, without interfering with wound healing. Additionally, the dressings had a significantly lower adhesion to the wound bed. Our antimicrobial wound dressings reduced the burden of clinically relevant bacteria more than commercial antimicrobial wound dressings. In an in vivo infected burn wound model, our coatings performed as well or better than bacitracin. We anticipate that our wound dressings would be useful for the treatment of various types of acute and chronic wounds.
参考来源
- Dhyani A, Repetto T, VanAken S, et al. ANTIMICROBIAL WOUND DRESSINGS FOR FULL-THICKNESS INFECTED BURN WOUNDS. Shock. 2024. PMID: 39158545. doi:10.1097/SHK.0000000000002426
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。